Introduced as Aromasin in 2000, Exemestane is a powerful aromatase inhibitor that prevents estrogen conversion, effectively reducing estrogen levels by up to 85%. Initially developed for postmenopausal women with advanced breast cancer, it gained popularity among athletes for its ability to prevent estrogenic side effects during steroid cycles. Unlike other aromatase inhibitors, Exemestane is a steroidal compound, making it irreversible in its action, effectively blocking estrogen production without affecting testosterone levels significantly .
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Aromasin 10 by Prime Pharma, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.